AC Immune (ACIU) Change in Interest Receivables (2015 - 2023)
AC Immune's (ACIU) quarterly Change in Interest Receivables came in at $205420.9 in Q1 2023, down 77.09% year-on-year from $896565.3 in Q1 2022, and down 48.87% on a QoQ basis from $401757.2 in Q3 2022.
AC Immune (ACIU) Change in Interest Receivables (2015 - 2023) Analysis & Trends
AC Immune (ACIU) has 9 years of Change in Interest Receivables data on file, last reported at $205420.9 in Q1 2023.
- On a quarterly basis, Change in Interest Receivables fell 77.09% year-over-year to $205420.9 in Q1 2023; TTM through Mar 2023 was $1.2 million, a 51.05% decrease from a year earlier, with the FY2016 full-year figure at -$855069.2, down 13806.33% from the prior year.
- Change in Interest Receivables for Q1 2023 stood at $205420.9, down from $401757.2 in the prior quarter.
- Over the last five years, Change in Interest Receivables for ACIU reached as high as $2.9 million in Q1 2019 and fell as low as -$565996.4 in Q3 2020.
- Historically, Change in Interest Receivables has averaged $436018.9 across 5 years, with a median of $265283.9 in 2019.
- Across the five-year window, Change in Interest Receivables tumbled 1498.02% in 2019 and jumped 211.03% in 2021, its largest moves.
- Year by year, Change in Interest Receivables stood at -$397860.9 in 2019, then sank by 42.26% to -$565996.4 in 2020, then soared by 211.03% to $628427.5 in 2021, then tumbled by 36.07% to $401757.2 in 2022, then plunged by 48.87% to $205420.9 in 2023.
- Per Business Quant data, the three most recent Change in Interest Receivables figures were $205420.9 in Q1 2023, $401757.2 in Q3 2022, and -$286568.9 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -266,893.98 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | AC Immune | 222.66 Mn | 222.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 205,420.89 |
| Sep 30, 2022 | 401,757.17 |
| Jun 30, 2022 | -286,568.87 |
| Mar 31, 2022 | 896,565.34 |
| Sep 30, 2021 | 628,427.50 |
| Jun 30, 2021 | 65,798.83 |
| Mar 31, 2021 | 895,907.84 |
| Sep 30, 2020 | -565,996.42 |
| Jun 30, 2020 | -216,902.68 |
| Mar 31, 2020 | 910,818.85 |
| Sep 30, 2019 | -397,860.93 |
| Jun 30, 2019 | 265,283.90 |
| Mar 31, 2019 | 2.87 Mn |
| Sep 30, 2018 | 28,458.90 |
| Jun 30, 2018 | -1.51 Mn |
| Mar 31, 2018 | 1.74 Mn |
| Sep 30, 2017 | 62.56 Mn |
| Jun 30, 2017 | -555,204.29 |
| Mar 31, 2017 | 355,558.96 |
| Dec 31, 2016 | -502,012.27 |